title: Epoetin alfa for predialysis and AZT-treated HIV-positive patients.
abstract: PROCRIT is an exogenous form of erythropoietin now marketed for use in anemic predialysis patients and AZT-treated HIV-positive patients. It is the same preparation as epogen. It will be up to the physician to determine which form of the drug is prescribed for each patient. Cost issues will probably be a deciding factor as the products are identical. Key differences to keep in mind are that predialysis patients will have to come in to the clinic two or three times a week for injections as they are are not on dialysis and that payment issues could be a problem.
authors.forename: M J
authors.initials: MJ
authors.lastname: Holechek
mesh_terms: D000740:Anemia / Q000451:nursing / Q000628:therapy*; D004921:Erythropoietin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006679:HIV Seropositivity / Q000451:nursing / Q000628:therapy*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*; D015215:Zidovudine / Q000627:therapeutic use
chemical_list: D004921:Erythropoietin; D015215:Zidovudine